Transgene
Biotechnology ResearchGrand Est, France51-200 Employees
Cancer immunotherapy Transgene (Euronext: TNG) is a clinical stage biotechnology company focused on individualized therapeutic vaccines
Innovative Immunotherapies Transgene specializes in cutting-edge cancer immunotherapy research, presenting opportunities to collaborate on novel treatments leveraging advanced biotech solutions for oncology.
Moderate Financial Scale With revenue between 1 and 10 million dollars and 45 million in funding, Transgene is positioned for growth, potentially seeking strategic partnerships and investment to expand its pipeline.
Technology Adoption The company's use of sophisticated digital tools suggests a strong emphasis on innovative tech integration, opening doors for technology providers in web optimization, analytics, and cloud services.
Targeted Market Niche Focusing on cancer immunotherapies allows access to a specialized and rapidly evolving sector, ideal for partnering with organizations offering complementary research, clinical development, and commercialization expertise.
Smaller Company Flexibility As a midsize enterprise with up to 200 employees, Transgene offers flexibility and agility for strategic collaborations, making it suitable for companies seeking adaptable partners in biotech innovation.
Transgene uses 8 technology products and services including Site Kit, LiteSpeed Cache, Cloudflare, and more. Explore Transgene's tech stack below.
| Transgene Email Formats | Percentage |
| Last@transgene.fr | 62% |
| FirstLast@transgene.fr | 23% |
| First.Last@transgene.fr | 9% |
| F.Last@transgene.fr | 2% |
| FLast@transgene.fr | 1% |
| First.MiddleLast@transgene.fr | 1% |
| First.Middle@transgene.fr | 1% |
| FL@transgene.fr | 1% |
Biotechnology ResearchGrand Est, France51-200 Employees
Cancer immunotherapy Transgene (Euronext: TNG) is a clinical stage biotechnology company focused on individualized therapeutic vaccines
Transgene's revenue is estimated to be in the range of $1M$10M
Transgene's revenue is estimated to be in the range of $1M$10M